These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model. Lange S; Altmann S; Brandt B; Adam C; Riebau F; Vogel H; Weirich V; Hilgendorf I; Storb R; Freund M; Junghanss C Exp Hematol; 2009 Jan; 37(1):143-50. PubMed ID: 19100524 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902. Foss FM; Wang XV; Luger SM; Jegede O; Miller KB; Stadtmauer EA; Whiteside TL; Avigan DE; Gascoyne RD; Arber D; Wagner H; Strair RK; Hogan WJ; Sprague KA; Lazarus HM; Litzow MR; Tallman MS; Horning SJ Transfusion; 2020 Aug; 60(8):1867-1872. PubMed ID: 32654201 [TBL] [Abstract][Full Text] [Related]
9. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426 [TBL] [Abstract][Full Text] [Related]
10. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265 [TBL] [Abstract][Full Text] [Related]
11. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation. Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082 [TBL] [Abstract][Full Text] [Related]
12. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation. Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation. Mielcarek M; Torok-Storb B; Storb R Biol Blood Marrow Transplant; 2011 Aug; 17(8):1255-60. PubMed ID: 21220032 [TBL] [Abstract][Full Text] [Related]
14. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. Foss FM Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113 [TBL] [Abstract][Full Text] [Related]
15. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149 [TBL] [Abstract][Full Text] [Related]
16. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation? Diaconescu R; Little MT; Leisenring W; Yunusov M; Hogan WJ; Sorror ML; Baron F; Storb R Biol Blood Marrow Transplant; 2005 May; 11(5):335-44. PubMed ID: 15846286 [TBL] [Abstract][Full Text] [Related]
17. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning. Graves SS; Hogan W; Kuhr CS; Diaconescu R; Harkey MA; Georges GE; Sale GE; Zellmer E; Baran SW; Jochum C; Stone B; Storb R Blood; 2007 Jul; 110(1):418-23. PubMed ID: 17369487 [TBL] [Abstract][Full Text] [Related]
18. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175 [TBL] [Abstract][Full Text] [Related]
19. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model. Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218 [TBL] [Abstract][Full Text] [Related]
20. Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts. Graves SS; Storer BE; Butts TM; Storb R Biol Blood Marrow Transplant; 2013 Nov; 19(11):1650-4. PubMed ID: 23994246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]